Proline-rich polypeptide-1 protects the cells in vitro from genotoxic effects of mitomycin C

Neurochemical Research

Volumn 35, Issue 4, 2010, Pages 598-602

  Aroutiounian, R M ^a   Hovhannisyan, G G ^a   Gasparyan, G H ^a,b   Margaryan, K S ^a   Aroutiounian, D N ^a   Sarkissyan, N K ^b   Galoyan, A A ^c  

^a YEREVAN STATE UNIVERSITY   (Armenia)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^c H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

Author keywords

Cells in vitro; Comet assay; Micronucleus induction test; Mitomycin C; Proline rich polypeptide 1; Protection

Indexed keywords

MITOMYCIN C; PROLINE RICH POLYPEPTIDE 1; PROLINE RICH PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CHROMOSOME DAMAGE; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DAUGHTER CELL; DNA DAMAGE; DRUG ACTIVITY; DRUG MECHANISM; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MICRONUCLEUS TEST; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ANTIMUTAGENIC AGENTS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; HUMANS; MICRONUCLEUS TESTS; MITOMYCIN; MUTAGENS; PEPTIDES;

EID: 77953534305     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0104-8     Document Type: Article

References (26)

1. Galoyan AA (1997) Biochemistry of novel cardioactive hormones and immunomodulators of the functional system neurosecretory hypothalamus-endocrine heart. Moscow, Nauka Publishers, p 233
2. Galoyan AA (2000) Neurochem Res 25:1343-1355
3. Aprikyan VS, Galoyan KA, Galoyan AA (1998) Neurochem (RAS & NAS RA) 15:189-195
4. Aprikyan VS, Galoyan AA (1999) Med Sci Armenia 31:29-36
5. Aprikyan VS, Galoyan KA, Galoyan AA (1999) J Neurochem 77, suppl. S68D
6. Aprikyan VS, Chailian SG, Galoyan AA (2001) Med Sci Armenia 41:72-77
7. Galoyan AA (2004) Brain neurosecretory cytokines; immune response and neuronal survival. Kluwer Academic/Plenum Publishers, New York, p 188
8. Aprikyan VS, Galoyan AA (2000) Neurochimiya 17:60-63
9. Aprikyan VS, Galoyan AA (2001) Proceedings International Conference "Biochemical and Molecular-Biological Aspects of Brain Immune System", Yerevan, pp 183-189
10. Galoyan AA, Aprikyan VS (2002) Neurochem Res 27:305-312
11. Davtyan TK, Manukyan HM, Hakopyan GS (2005) Neurochem Res 30:297-309
12. Galoyan AA, Sarkissian JS, Kipriyan TK et al (2000) Neurochem Res 25:1567-1578
13. Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen & Co, London
14. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) Exp Cell Res 175:184-191
15. Goethem FV, Lison D, Volders MK (1997) Mutation Res 392:31-43
16. Galoyan AA, Margaryan KS, Havhannisyan GG et al (2009) Neurochem 3:145-148
17. Fairbairn DW, Olive PL, O'Neill KL (1995) Mutation Res 339:37-59
18. Mozaffarieh M, Schoetzau A, Sauter M et al (2008) Mol Vis 14:1584-1588
19. Fenech, M. F. (1996) Technologies for Detection of DNA Damage and Mutations. In: Pfeifer GP (ed) New York: Plenum Press, Chapter 2, pp 25-36
20. Fenech MF (2000) Mutation Res 455:81-95
21. Parry JM (1998) A proposal for a new OECD guideline for the in vitro micronucleus test. URL: http://www.swan.ac.uk/cget/ejgt/article MN UKEMS Protocol.htm
22. Heddle JA (1973) Mutation Res 18:187-190
23. Mohanty SK, Rapp A, Monajembashi S et al (2002) Radiation Res 157:378-385
24. Olive PL, Wlodek D, Banath JP (1991) Cancer Res 51:4671-4676
25. Merk O, Speit G (1999) Environ Mol Mutagen 33:167-172
26. Hovhannisyan G, Aroutiounian R, Glei M (2009) Toxicol In Vitro 23:1028-1033